Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2015 October;106(5) > Minerva Medica 2015 October;106(5):309-13

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

CORRESPONDENCE  


Minerva Medica 2015 October;106(5):309-13

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Impact of genetic signature on breast cancer therapy: preliminary experience

Rulli A. 1, 2, Listorti C. 1, 2, Foglietta J. 3, Burattini M. F. 4, Caracappa D. 1, Palumbo I. 5, Barberini F. 1, 2, Covarelli P. 4, Boselli C. 2

1 Breast Unit, Department of Surgical Oncology, University of Perugia, Perugia, Italy; 2 Department of Surgical Oncology, University of Perugia, Perugia, Italy; 3 Department of Medical Oncology, Santa Maria della Misericordia Hospital, Perugia, Italy; 4 Department of Surgical Oncology, University of Perugia, Perugia, Italy; 5 Department of Oncological Radiotherapy, Santa Maria della Misericordia Hospital, Perugia, Italy;


PDF  


top of page

Publication History

Cite this article as

Rulli A, Listorti C, Foglietta J, Burattini MF, Caracappa D, Palumbo I, et al. Impact of genetic signature on breast cancer therapy: preliminary experience. Minerva Med 2015 October;106(5):309-13. 

Corresponding author e-mail

chiaralist@gmail.com